ORIGINAL RESEARCH

Associations between SNPs in the genes encoding urokinase system proteins and the risk of placental insufficiency

Revina DB1, Balatskiy AV1,2, Larina EB3, Oleynikova NA1, Mishurovsky GA1, Malkov PG1, Samokhodskaya LM1, Panina OB1, Tkachuk VA1,2
About authors

1 Lomonosov Moscow State University, Moscow, Russia

2 National Medical Research Center for Cardiology, Moscow, Russia

3 Lapino Clinical Hospital "Mother and Child", Moscow, Russia

Correspondence should be addressed: Daria B. Revina
Lomonosovsky prospect, 27, k.1, Moscow, 119192; moc.liamg@airad.ayaksnizol

About paper

Funding: this study was conducted under the state assignment for Lomonosov Moscow State University using the equipment acquired as part of the Scientific Development Program of Lomonosov Moscow State University.

Acknowledgement: the authors thank Mamedov NN, PhD Med, an Assistant Professor at the Department of Obstetrics and Gynecology (Faculty of Fundamental Medicine, Lomonosov Moscow State University) for his help in creating the collection of biosamples (umbilical cord fragments, blood samples).

Author contribution: Revina DB, Balatskiy AV, Larina EB, Samokhodskaya LM, Panina OB, Tkachuk VA — study design; Revina DB, Balatskiy AV, Larina EB, Oleynikova NA, Mishurovsky GA — collection and processing of biosamples and clinical datal; Revina DB, Balatskiy AV, Mishurovsky GA — statistical analysis; Revina DB, Balatskiy AV — interpretation of the results; Revina DB, Balatskiy AV, Oleynikova NA, Mishurovsky GA — manuscript preparation; Malkov PG, Samokhodskaya LM, Panina OB, Tkachuk VA — manuscript revision; Revina DB and Balatskiy AV equally contributed to the study.

Received: 2019-10-31 Accepted: 2019-11-18 Published online: 2019-12-07
|
  1. Benirschke K, Burton GJ, Baergen RN. Pathology of the Human Placenta, 6th ed. Springer, 2012; p. 411.
  2. Poettler M, Unseld M, Mihaly-Bison J, Uhrin P, Koban F. Binder BR, et al. The urokinase receptor (CD87) represents a central mediator of growth factor-induced endothelial cell migration. Thromb Haemost. 2012; 108 (8): 357–66.
  3. Tkachuk VA, Plekhanova OS, Parfyonova YV. Regulation of arterial remodeling and angiogenesis by urokinase-type plasminogen activator. Can J Physiol Pharmacol. 2009; 87 (4): 231–51.
  4. Khosravi F, Zarei S, Ahmadvand N, Akbarzadeh-Pasha Z, Savadi E, Zarnani A, et al. Association between plasminogen activator inhibitor 1 gene mutation and different subgroups of recurrent miscarriage and implantation failure. J Assist Reprod Genet. 2014; 31 (1): 121–4.
  5. Zhao L, Bracken MB, DeWan AT, Chen S. Association between the SERPINE1 (PAI-1) 4G/5G insertion/deletion promoter polymorphism (rs1799889) and pre-eclampsia: A systematic review and meta-analysis. Molecular Human Reproduction. 2013; 19 (3): 136–43.
  6. Tran H, Maurer F, Nagamine Y. Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated protein kinase 2. Mol Cell Biol. 2003; 23 (20): 7177–88.
  7. Xu J, Li W, Bao X, Ding H, Chen J, Zhang W, et al. Association of putative functional variants in the PLAU gene and the PLAUR gene with myocardial infarction. Clin Sci (Lond). 2010; 119 (8): 353–9.
  8. Yosrlimoto M, Youichi, Ushiyama Y, Sakaia M, Tamakia S, Hara H, et al. Characterization of single chain urokinase-type plasminogen activator with a novel amino-acid substitution in the kringle structure. Biochimica et Biophysica Acta (BBA)-Protein Structure and Molecular Enzymology. 1996; 1293 (1): 83–9.
  9. Campbell DB, Li C, Sutcliffe JS, Persico AM, Levitt P. Genetic evidence implicating multiple genes in the met receptor tyrosine kinase pathway in autism spectrum disorder. Autism Res. 2008; 1 (3): 159–68.
  10. Solé X, Guinó E, Valls J, Iniesta R, Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics. 2006; 22 (15): 1928–29.
  11. Martínez-Hernández MG, Baiza-Gutman LA, Castillo-Trápala A, Armant DR. Regulation of proteinases during mouse peri-implantation development: Urokinase-type plasminogen activator expression and cross talk with matrix metalloproteinase 9. Reproduction. 2011; 141 (2): 227.
  12. Lash GE, Otun HA, Innes BA, Percival K, Searle RF, Robson SC, et al. Regulation of extravillous trophoblast invasion by uterine natural killer cells is dependent on gestational age. Hum Reprod. 2010; 25 (5): 1137–45.
  13. Naruse K, Lash GE, Bulmer JN, Innes BA, Otun HA, Searle RF, et al. The Urokinase Plasminogen Activator (uPA) System in Uterine Natural Killer Cells in the Placental Bed During Early Pregnancy. Placenta. 2009; 30 (5): 398–404.
  14. Pierleoni C, Castellucci M, Kaufmann P, Lund LR, Schnack Nielsen B, Urokinase receptor is up-regulated in endothelial cells and macrophages associated with fibrinoid deposits in the human placenta. Placenta. 2003; 24 (6): 677–85.
  15. Breuss JM, Uhrin P. VEGF-initiated angiogenesis and the uPA/ uPAR system. Cell adhesion & migration. 2012; 6 (6): 535–40.
  16. Liu S, Zheng Q, Cui XY, Dai KX, Yang XS, Li FS, et al. Expression of uPAR in human trophoblast and its role in trophoblast invasion. Int J Clin Exp Pathol [Internet]. e-Century Publishing Corporation; 2015; 8 (11): 14325–34. Available from: https://www.ncbi.nlm. nih.gov/pmc/articles/PMC4713534/.
  17. Xu Z, Meng L-L, Lin J, Ling Y, Chen S, Lin N. Association between the polymorphisms of urokinase plasminogen activation system and cancer risk: a meta-analysis. Onco Targets Ther [Internet]. Dove Medical Press. 2015; 9 (8): 2493–502. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574847/.
  18. Andreasen P, Kjøller L, Christensen L, Duffy MJ. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer. 1997; 72 (1): 1–22.
  19. Duffy MJ, Maguire TM, McDermott EW, O’Higgins N. Urokinase plasminogen activator: a prognostic marker in multiple types of cancer. J Surg Oncol. 1999; 71 (2): 130–5.
  20. Fuhrman B. The urokinase system in the pathogenesis of atherosclerosis. Atherosclerosis. Ireland; 2012 May; 222 (1): 8–14.
  21. Diamandis M, Paterson AD, Rommens JM, Veljkovic DK, Blavignac J, Bulman DE, et al. Quebec platelet disorder is linked to the urokinase plasminogen activator gene (PLAU) and increases expression of the linked allele in megakaryocytes. Blood. 2009; 113 (7): 1543–6.